Skip to main content
Ortho, Thermo Fisher's BRAHMS partner on PCT assay development

Ortho Clinical Diagnostics and Thermo Fisher Scientific's BRAHMS announced a strategic relationship aimed at developing the BRAHMS PCT assay for use on Ortho's Vitros immunodiagnostics and integrated systems. The procalcitonin assay, designed to aid in sepsis management along with the use of other laboratory findings and clinical assessment, helps determine which patients are at high risk of septic shock and when antibiotics can be safely discontinued.

Full Story: